NCT04057469

Tulobuterol Patch in Pediatric Patients Undergoing Tonsillectomy

Effect of Tulobuterol Patch Versus Placebo on the Occurrence of Respiratory Adverse Events in Children Undergoing Tonsillectomies

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 182 (actual)
• Sponsor: Seoul National University Hospital · Academic / Other
• Sex: All
• Age: 3 Years – 6 Years
• Healthy volunteers: Not accepted

Summary

* Tonsillectomy is a common pediatric procedure for the treatment of sleep-disordered breathing and chronic tonsillitis. Up to half of children having this procedure experience a perioperative respiratory adverse event. * We tried to determine whether tulobuterol patch (transdermal bronchodilator) premedication decreases the risk of perioperative respiratory adverse events in children undergoing anesthesia for tonsillectomy.

Conditions

• Tonsillar Hypertrophy

Interventions

Type	Name	Description
DRUG	Tulobuterol Hydrochloride	The appropriate time interval between the patch attachment and the end of surgery was within 8 to 10 hours.
DRUG	Placebo transdermal patch	The appropriate time interval between the patch attachment and the end of surgery was within 8 to 10 hours.

Timeline

• Start date: 2019-12-20
• Primary completion: 2021-09-30
• Completion: 2021-09-30
• First posted: 2019-08-15
• Last updated: 2022-01-14

Locations

4 sites across 1 country: South Korea